- Pagina principale
- Analisi dell'app gratuita
- Drug Calculations Game
Drug Calculations Game analisi dell'app per 9 dicembre
Drug Calculations Game
- Focus Games Ltd
- App Store di Apple
- A pagamento
- Settore Medico
Developed in partnership with City University London. This educational game is designed to test your drug calculation skills. It helps staff that are involved in dispensing or administering drugs to improve confidence and numeracy with the aim of reducing errors. Most nursing roles require you to pass a numeracy test. The Drug Calculations Game is an ideal practice game.
Audience
Suitable for all staff involved in dispensing and administering drugs, such as:
Nurses/student nurses
Junior doctors/medical students
Pharmacy staff
This mobile app is intended for informational and educational purposes only. Healthcare professionals should exercise their own independent clinical judgement when using the mobile app. Users of this mobile app should consult a qualified healthcare professional before making any health, medical or other decision based on the data contained herein. Further information on any drug named in this app can be found https://bnf.nice.org.uk
Classifica degli store
La classifica del store si basa su diversi parametri stabiliti da Google e Apple.
Tutte le categorie in
Stati Uniti--
Settore Medico in
Stati Uniti--
Crea un account per visualizzare il numero mensile medio di downloadContattaci
Drug Calculations GameStatistiche di ranking nel tempo
Classifica di Utilizzo di Similarweb e Classifica App Store di Apple per Drug Calculations Game
Classifica degli store
Rank
Drug Calculations Game Classifica per paese
Paesi in cui Drug Calculations Game ha la posizione più alta nelle sue categorie principali
Principali concorrenti e app alternative
App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.
Dose Chex
Lindum Medical Ltd
CliniCal Calculator
DOCTORS HANDBOOKS LTD
Keffort (Hee)
Netop Industrial Company Limited
ONE LDN
ONE LDN 360 LTD
9icembre d, 2025